Thyroid Disease Perspective

 
 
  • Optimal Thyroid Health for All   With a focus on diversity, equity, and inclusion, the recent American Thyroid Association meeting looked at optimizing thyroid health. Maria Papaleontiou, MD, presents highlights from the meeting.
  • ATA 2022 Read clinically focused news coverage of key developments from ATA 2022
  • State of the Art in NAFLD/NASH Identification and Management   Drs Seth Baum and Jay Shubrook explore the highly anticipated Clinical Care Pathway for the screening, diagnosis, and treatment of NAFLD/NASH.
  • Don't Overlook NAFLD in Lean Patients Dr Nancy Reau speaks with gastroenterologist Dr Michelle Long about the challenges of identifying and treating NAFLD in patients without obesity.
  • What's New on the Lipid Management Landscape?   Drs Pam Taub and Steve Nissen discuss the current state of lipid management and what is on the horizon, thanks to the impact of highly anticipated new therapies to join the armamentarium.
  • Can a Fitbit or Apple Watch Help Fight Thyroid Disease? With the increasing use of wearable devices that capture health data points, physicians can use this information to accurately assess their patients' symptoms, even remotely.
  • Diffuse Urticarial Eruptions After COVID-19 Vaccination Many common side effects of the COVID-19 vaccine are dermatologic. Dr Stadtmauer discusses seven patients he has treated personally.
  • Is Long-Term Antithyroid Use the Best Treatment for Graves Disease?   Drs Angela Leung, Whitney Goldner, and David Cooper discuss long-term antithyroid use for managing Graves disease.
  • ENDO 2022 Read clinically focused news coverage of key developments from ENDO 2022
  • Recording Weight Advisable at All Ages in General Medicine In general practice, recording a patient's weight helps detect those at risk of metabolic syndrome, but this task is not performed routinely for men or patients with no comorbidities.
  • RCC e-Tumor Boards: Case 2: High-Risk Localized RCC   The Kidney Cancer Team from Memorial Sloan Kettering Cancer Center discusses adjuvant treatment strategies for a patient with high-risk localized RCC.
  • Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  • AACE 2022 Read clinically focused news coverage of key developments from AACE 2022
  • Why Iodized Salt Is Important for You and Your Thyroid Lack of iodine can lead to thyroid deficiency disorders. Dr Elizabeth Pearce discusses iodized salt, its importance, and how to increase iodine intake.
  • Graves Disease, Thyroid Eye Disease, and COVID-19 Is there a link between COVID-19 cases or vaccinations and the increased reports of thyroid autoimmunity and its complications? Drs McLeod and Balcerek attempt to answer this question.
  • Endocrine System Vulnerable to Disruption From COVID-19 COVID-19 may disrupt the endocrine system, making people vulnerable to thyroid, pituitary, and gonad issues even after recovery.
  • Endocrine Care for Childhood Cancer Survivors   Children who have been through cancer treatment may face a range of endocrine issues. Dr Jessica Lilley interviews Dr. Priyanka Bakhtiani about optimizing care for these kids.
  • What Role Does Loneliness Play in Diabetes Risk? Can loneliness lead to chronic physical ailments? Dr Richard Plotzker reviews the literature and discusses adverse outcomes related to social isolation.
  • Vitamin D Supplements Cut Risk for Autoimmune Disease   The VITAL study assessed the effects of vitamin D and omega-3 fatty acid supplements on autoimmune disease incidence.
  • Serotonin Syndrome? Not So Fast, Sherlock My patient's confusion and tremors persisted after her serotonergic meds were stopped. Then I asked her husband when she was last like her old self, and the diagnosis became clear.